In brief: New execs at Insulet & Synapse, state of e-prescribing, OPGA & Össur awards 

ACTON, Mass. – Insulet has appointed Ashley McEvoy as president and CEO effective immediately, replacing Jim Hollingshead, who has agreed to end his employment at the company and resign from its board of directors.  

“Insulet continues to successfully deliver on its financial, clinical and operational objectives while advancing its mission to improve the lives of people with diabetes, and we are confident this leadership change will further the company’s success,” said Timothy Scannell, chairman of Insulet’s board of directors. “Having stepped into the CEO role from the board of directors, Jim has led Insulet through a very strong period of growth and development. We’re grateful for his contributions, and we wish him the best in his future endeavors.” 

Hollingshead, who joined Insulet in 2022, previously served as president of ResMed’s Sleep and Respiratory Care business. 

McEvoy has previously held roles as executive vice president and worldwide chairman of Johnson & Johnson’s MedTech business. She has deep diabetes experience, having previously served as group chairman of Johnson & Johnson Vision and Diabetes Care.  

“Insulet has transformed diabetes care, and I am honored to join the company as its next CEO,” said McEvoy. “Insulet has massive, untapped growth potential, a talented team, unparalleled pharmacy channel access and manufacturing capabilities, and deeply loyal customers – remarkable differentiators and a strong foundation for continued success. At this critical moment in the company and market’s evolution, Insulet has a unique opportunity to enhance innovation, drive global expansion, and win the hearts and minds of more providers and consumers by thinking differently about the experiences and needs of people with diabetes.” 

OPGA, Össur announce grant recipients 

WATERLOO, Iowa – OPGA and Össur Americas have announced the recipients of two O&P grants. Avery-Claire Littleton has been selected as the 2025 recipient of the Russell Walker CP, LP Emerging Leader Grant, and Nicole Bakovich has been selected as the 2025 recipient of the Todd Eagen Advocacy in Action Memorial Grant.  

“We are excited to announce Avery-Claire and Nicole as the recipients of these two grants that will help them grow their careers and contribute to the field of O&P," said Nikki Grace, director of OPGA. “In partnership with Össur, we look forward to watching Avery-Claire and Nicole advance the O&P profession as the next generation of O&P leaders in their journey to enhance mobility and improve lives.”  

Both annual grants are designed to provide funding to O&P residents and certified orthotists or prosthetists that will allow them to attend and participate in two non-clinical events in the O&P profession: an advocacy event and the Challenged Athletes Foundation Triathlon Challenge. “Össur is committed to helping people world-wide improve their mobility with our innovative prosthetic solutions, which is why Össur has partnered with organizations like OPGA to come together and offer professional development opportunities for the future leaders of O&P while memorializing Russell Walker and Todd Eagen,” said Frances Thorpe, marketing & communications manager with Össur. “Össur is looking forward to supporting our next generation of residents, enhancing and elevating their future in the O&P profession.” 

For more information about the Russell Walker CP, LP Emerging Leader Grant, click here. 

For more information about the Todd Eagen Advocacy in Action Memorial Grant, click here. 

• Related: Get to know last year’s award recipients, Matthew Jones and Kelley Berk. 

Parachute Health sees increase in e-prescribe adoption 

NEW YORK – Parachute Health’s e-prescribing platform is now being used in more than 3,000 supplier locations and 70,000 clinical facilities, according to its latest State of DME ePrescribing report, which includes data through Jan 1, 2025. The report showcases significant growth in digital ordering, deeper engagement from health plans and advancements in AI-powered automation. It also provides a guide on adoption of DME e-prescribing across care settings and categories; platform data & key trends; and opportunities for clinicians, suppliers, manufacturers, health plans, hospital systems and other health care professionals in 2025 and beyond. Additionally, the report highlights key milestones in 2024, including AI intake, integrated prior authorization and improvements in patient engagement. Click here to read the full report. 

Synapse Health taps former Integra exec as new CFO 

SKOKIE, Ill. – Synapse Health has named Jay Shah as CFO. He joins Synapse's expanding executive leadership team, bringing 20 years of deep expertise in finance and the DME ecosystem to the role, most recently at Integra Partners, where he served as CFO. “Jay’s strong business acumen and hands-on experience in the DME industry make him an exciting addition to our growing leadership team,” said Cory Roberts, co-founder and CEO of Synapse Health. “Having someone of his caliber join our mission to improve the DME experience for patients, prescribers and DME providers underscores the power and promise of our unique, tech-enabled model. He will be a key leader in our efforts to transform the DME industry toward value-based care.” Shah has also held several leadership roles at American Express Company, including vice president and CFO, global commercial payments, where he oversaw operating results across the U.S., Canada and Latin America. Additionally, he has served as vice president and CFO at Global Prepaid Group and Global Real Estate Group. “Joining Synapse allows me to leverage the lessons I’ve learned in the DME space to advance a more streamlined, patient-centered experience for all stakeholders,” said Shah. “I look forward to supporting the expansion of our DME provider network and finding new ways to foster mutually beneficial partnerships across the industry. The data is clear: There’s tremendous potential to improve outcomes and satisfaction across the board, and I’m proud to be part of a team dedicated to meaningful, industry-wide transformation.” 

• Related: Synapse Health also appointed Mandira Singh as president earlier this month. 

Tandem sees sales increase in Q1 

SAN DIEGO – Tandem Diabetes Care reported that worldwide sales increased to $234.4 million for its first quarter 2025, an increase of 22% compared to the same quarter in 2024. Pump sales in the U.S. grew by 19% on a GAAP basis and 17% on a non-GAAP basis, on strong shipment growth and average selling price improvement, with the company shipping more than 17,000 pumps in the U.S. and 11,000 outside the U.S. “The strength of our first quarter performance was driven by more than 20% worldwide sales growth, including our highest quarter ever outside the United States,” said John Sheridan, president and CEO. “We are creating new possibilities for people living with diabetes, while delivering record results that align with our 2025 and long-term financial goals for sustained, double-digit sales growth and profitability.” Other highlights in the quarter: a 5-point adjusted EBITDA margin increase; a milestone of approximately 30% of U.S. lives now covered through pharmacy benefits for Tandem Mobi; and a feature in the New England Journal of Medicine on the benefits of Control-IQ Technology for the fourth time. 

Florida man convicted of $10.9M in brace fraud 

TAMPA, Fla. – A federal jury has found Lino Mallari Gutierrez of Palm City, Fla., guilty of conspiracy to commit health care and wire fraud, conspiracy to violate the federal anti-kickback statute, five substantive counts of health care fraud and four substantive counts of payment of kickbacks in connection with a heath care program. According to testimony and evidence presented at trial, Gutierrez and his co-conspirators owned and operated two DME companies that collectively billed Medicare more than $10.9 million for medically unnecessary braces, of which more than $5 million was paid to Gutierrez and his co-conspirators. Gutierrez concealed his role in the scheme by putting the DME companies in the names of straw owners, and was in the process of establishing four more DME companies with additional straw owners—including Gutierrez’s mother and two of Gutierrez’s friends—when the U.S. Department of Health and Human Services-Office of Inspector General and the Federal Bureau of Investigation identified the DME fraud through a national operation. Prior to law enforcement action, Gutierrez had already taken multiple steps to use these additional DME companies to bill Medicare for additional fraudulent claims. After learning of law enforcement action, Gutierrez moved Medicare proceeds from his account into other bank accounts under his control. Gutierrez was remanded into custody and faces a maximum penalty of 20 years in federal prison.  

Invacare tees up second ‘Move For Mobility’ campaign 

ELYRIA, Ohio – Invacare is launching its second “Move For Mobility” fundraising and activity campaign in Europe and Asia Pacific, building on the success of last year's campaign with partner Free Wheelchair Mission. “Move For Mobility” encourages and inspires employees, their families, and the company’s partners to get moving while raising money and awareness for Free Wheelchair Mission, a non-profit organization that provides wheelchairs at no cost to individuals with disabilities in remote communities worldwide. “In 2024, I had the privilege of personally delivering wheelchairs to the Dominican Republic,” said Geoff Purtill, president and CEO of Invacare. “Seeing the impact up close was incredibly moving. This year, we’re aiming even higher—uniting employees, ambassadors, customers, and partners across the globe to help more people access something as basic, yet life-changing, as a wheelchair.” Last year, 425 Invacare employees across regions raised more than $28,000 during the inaugural “Move For Mobility,” which funded the distribution of 294 wheelchairs and transformed the lives of many individuals in developing countries. 

• Related: Invacare employees raise $28K for wheelchair mission. 

Report: Aging trends boost home care growth 

BOSTON – An aging U.S. population and consumer preference for home care and aging-in-place are expanding the home care market, according to the April 2025 Home Care Sector Update from Capstone Partners. Key sector trends in 2025 include rising labor costs and ongoing labor shortages, accelerating adoption of technology, enhancing need for payer and service diversification, and significantly increasing Q1 2025 M&A activity as investors target well-positioned businesses, the report says. The report also includes insight on: 

• Which five key attributes investors prioritize in an acquisition target 

• What best practices home care agencies can implement to both thrive independently and drive maximum value in an exit. 

• How business owners can mitigate risk in the evolving regulatory environment.   

• To access to full report, click here.